The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient

被引:31
|
作者
Gopalakrishna, Ajay [1 ]
Longo, Thomas A. [1 ]
Fantony, Joseph J. [1 ]
Owusu, Richmond [2 ]
Foo, Wen-Chi [3 ]
Dash, Rajesh [3 ]
Inman, Brant A. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Urol, Durham, NC 27710 USA
[2] Univ Calif San Diego, Dept Urol, San Diego, CA 92103 USA
[3] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
来源
BMC UROLOGY | 2016年 / 16卷
基金
美国国家卫生研究院;
关键词
FISH; Cytology; Bladder cancer; Sensitivity; Specificity; Spectrum effects; SPECTRUM BIAS; CARCINOMA; INTEROBSERVER; EXPRESSION; GUIDELINES; MANAGEMENT; CYTOLOGY; GENDER; STAGE;
D O I
10.1186/s12894-016-0147-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, race, and smoking status on the performance characteristics of two commonly used diagnostic tests for bladder cancer, urine cytology and fluorescence in situ hybridization (FISH). Methods: We assessed all subjects who underwent cystoscopy, cytology, and FISH at our institution from 2003 to 2012. The standard diagnostic test performance metrics were calculated using marginal models to account for clustered/repeated measures within subjects. We calculated test performance for the overall cohort by test indication as well as by key patient variables: age, gender, race, and smoking status. Results: A total of 4023 cystoscopy-cytology pairs and 1696 FISH-cystoscopy pairs were included in the analysis. In both FISH and cytology, increasing age, male gender, and history of smoking were associated with increased sensitivity and decreased specificity. FISH performance was most impacted by age, with an increase in sensitivity from 17 % at age 40 to 49 % at age 80. The same was true of cytology, with an increase in sensitivity from 50 % at age 40 to 67 % at age 80. Sensitivity of FISH was higher for a previous diagnosis of bladder cancer (46 %) than for hematuria (26 %). Test indication had no impact on the performance of cytology and race had no significant impact on the performance of either test. Conclusions: The diagnostic performance of urine cytology and FISH vary significantly according to the patient demographic in which they were tested. Hence, the reporting of spectrum effects in diagnostic tests should become part of standard practice. Patient-related factors must contextualize the clinicians' interpretation of test results and their decision-making.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Bladder Cancer Screening with Urine-Based Tumour Markers - Occupational Medical Experience
    Nasterlack, M.
    Feil, G.
    Leng, G.
    Pesch, B.
    Huber, S.
    Sievert, K. -D.
    Johnen, G.
    Taeger, D.
    Mayer, T.
    Kluckert, M.
    Bruening, T.
    Stenzl, A.
    [J]. AKTUELLE UROLOGIE, 2011, 42 (02) : 128 - 134
  • [42] Validation of Urine-based Gene Classifiers for Detecting Bladder Cancer in a Chinese Study
    Han, Chengtao
    Mengual, Lourdes
    Kang, Bin
    Lozano, Juan Jose
    Yang, Xiaoqun
    Zhang, Cuizhu
    Alcaraz, Antonio
    Liang, Ji
    Ye, Dingwei
    [J]. JOURNAL OF CANCER, 2018, 9 (17): : 3208 - 3215
  • [43] Factors affecting the accuracy of urine-based biomarkers of BSE
    Margot Plews
    Lise Lamoureux
    Sharon LR Simon
    Catherine Graham
    Viola Ruddat
    Stefanie Czub
    J David Knox
    [J]. Proteome Science, 9
  • [44] Factors affecting the accuracy of urine-based biomarkers of BSE
    Plews, Margot
    Lamoureux, Lise
    Simon, Sharon L. R.
    Graham, Catherine
    Ruddat, Viola
    Czub, Stefanie
    Knox, J. David
    [J]. PROTEOME SCIENCE, 2011, 9
  • [45] Urine-based system tests HIV-1
    不详
    [J]. LABORATORY MEDICINE, 1998, 29 (08) : 459 - 459
  • [46] A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
    Hermanns, Thomas
    Savio, Andrea J.
    Olkhov-Mitsel, Ekaterina
    Mari, Andrea
    Wettstein, Marian S.
    Saba, Karim
    Bhindi, Bimal
    Kuk, Cynthia
    Poyet, Cedric
    Wild, Peter J.
    Noon, Aidan
    Bashir, Shaheena
    Juvet, Tristan
    Rendon, Ricardo A.
    Waltregny, David
    Kwast, Theodorus van der
    Finelli, Antonio
    Kulkarni, Girish S.
    Fleshner, Neil E.
    Lo, Kirk
    Bapat, Bharati
    Zlotta, Alexandre R.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 603.e1 - 603.e7
  • [47] BLCA-4, a highly specific marker urine-based markerof bladder cancer
    Van Le, TS
    Miller, R
    Barder, T
    Babjuk, M
    Potter, DM
    Getzenberg, RH
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 68 - 68
  • [48] Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
    Reinert, Thomas
    [J]. ADVANCES IN UROLOGY, 2012, 2012
  • [49] A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION
    Hermanns, Thomas
    Savio, Andrea J.
    Olkhov-Mitsel, Ekaterina
    Mari, Andrea
    Saba, Karim
    Bhindi, Bimal
    Gill, Bethany
    Sykes, Jenna
    Kuk, Cynthia
    Poyet, Cedric
    Wild, Peter J.
    Noon, Aidan
    Bashir, Shaheena
    Juvet, Tristan
    Rendon, Ricardo A.
    Waltregny, David
    van der Kwast, Theodorus
    Finelli, Antonio
    Kulkarni, Girish S.
    Fleshner, Neil E.
    Lo, Kirk
    Bapat, Bharati
    Zlotta, Alexandre R.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E313 - E314
  • [50] A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER
    Ghodoussipour, Saum
    Basin, Micheal F.
    Ahmadi, Hamed
    Seyedian, Seyedeh-Sanam Ladi
    Nusbaum, David J.
    Mitra, Anirban
    Piatti, Paolo
    Suwoto, Michiko
    Yamada, Taikun
    Gray, Matthew
    Jara, Benjamin
    Chew, Yap Ching
    Bhanvadia, Sumeet
    Djaladat, Hooman
    Schuckman, Anne
    Daneshmand, Siamak
    Liang, Gangning
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E232 - E232